Lanying Du, PhD
Researches in the Laboratory of Viral Immunology are focused on the development of antiviral therapeutic agents and vaccines for the treatment and prevention of HIV infection/AIDS and other emerging and remerging infectious diseases caused by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and influenza viruses, as well as the blood transfusion-related viruses, including zika virus (ZIKV) and West Nile virus (WNV).
Dr. Du received her Ph.D. from University of Hong Kong, and is currently an Associate Member of Viral Immunology Laboratory. Her research focuses on development of subunit vaccines and therapeutics against viruses causing emerging and remerging infectious diseases, and blood transfusion-related viruses, including SARS-CoV, MERS-CoV, influenza viruses, ZIKV, and HIV.
Phone: +1 (212) 570-3459